PROVITA DEVELOPMENT ApS — Credit Rating and Financial Key Figures

CVR number: 10009154
Korskildelund 4, 2670 Greve
christel@pharmavie.dk
tel: 56658828

Income statement (kDKK)

2016
2017
2018
2019
2020
Fiscal period length1212121212
Net sales
Gross profit25.9137.2153.882.69-5.80
EBIT25.9137.2153.882.69-5.80
Other financial income33.7226.345.350.02
Other financial expenses-20.14-15.65-1.10-0.68-1.48
Pre-tax profit39.4847.9052.787.37-7.27
Net earnings39.4847.9052.787.37-7.27

Assets (kDKK)

2016
2017
2018
2019
2020
Intangible assets total
Tangible assets total
Investments total
Long term receivables total
Inventories total
Current amounts owed by group member comp.583.21
Current other receivables29.9931.8140.335.352.51
Short term receivables total613.2031.8140.335.352.51
Cash and bank deposits56.23170.40222.72250.14246.97
Cash and cash equivalents56.23170.40222.72250.14246.97
Balance sheet total (assets)669.43202.21263.05255.50249.48

Equity and liabilities (kDKK)

2016
2017
2018
2019
2020
Share capital125.00125.00125.00125.00125.00
Retained earnings-22.0417.4465.35118.13125.50
Profit of the financial year39.4847.9052.787.37-7.27
Shareholders equity total142.44190.35243.13250.50243.23
Non-current liabilities total
Current trade creditors6.25
Current owed to group member513.50
Other non-interest bearing current liabilities13.4911.8619.925.00
Current liabilities total526.9911.8619.925.006.25
Balance sheet total (liabilities)669.43202.21263.05255.50249.48
Try the full version of our system for free
Bankruptcy risk visualization example

... and more!

No registration needed.